Gerasimov, M R <br/><br/>
Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.  [electronic resource] 

 -  Synapse (New York, N.Y.)  Dec 2000 
 - 432-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-4476 
<br/><br/><label>Standard No.: </label>10.1002/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carrier Proteins--antagonists & inhibitors<br/>Cocaine--pharmacology<br/>Dopamine--metabolism<br/>Dopamine Plasma Membrane Transport Proteins<br/>Dopamine Uptake Inhibitors--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Injections, Intraperitoneal<br/>Injections, Subcutaneous<br/>Male<br/>Membrane Glycoproteins<br/>Membrane Transport Proteins<br/>Methylphenidate--pharmacology<br/>Nerve Tissue Proteins<br/>Nicotine--pharmacology<br/>Nicotinic Agonists--pharmacology<br/>Nucleus Accumbens--metabolism<br/>Rats<br/>Rats, Sprague-Dawley